<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9500169</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20475</journal-id>
<journal-id journal-id-type="nlm-ta">Neurobiol Dis</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurobiol. Dis.</journal-id>
<journal-title-group>
<journal-title>Neurobiology of disease</journal-title>
</journal-title-group>
<issn pub-type="ppub">0969-9961</issn>
<issn pub-type="epub">1095-953X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29605426</article-id>
<article-id pub-id-type="pmc">5969806</article-id>
<article-id pub-id-type="doi">10.1016/j.nbd.2018.03.012</article-id>
<article-id pub-id-type="manuscript">NIHMS957875</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Translation-relevant EEG phenotypes in a mouse model of Fragile X
Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lovelace</surname>
<given-names>Jonathan W.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ethell</surname>
<given-names>Iryna M.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Binder</surname>
<given-names>Devin K.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Razak</surname>
<given-names>Khaleel A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Psychology, University of California, Riverside,
Riverside</aff>
<aff id="A2">
<label>2</label>Neuroscience Graduate Program, University of California, Riverside,
Riverside</aff>
<aff id="A3">
<label>3</label>Division of Biomedical Sciences, School of Medicine, University of
California, Riverside</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding Author Department of Psychology University of
California, 900 University Avenue, Riverside, CA – 92521
<email>Khaleel@ucr.edu</email> Phone: 951827-5060</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>17</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>29</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>7</month>
<year>2019</year>
</pub-date>
<volume>115</volume>
<fpage>39</fpage>
<lpage>48</lpage>
<!--elocation-id from pubmed: 10.1016/j.nbd.2018.03.012-->
<abstract>
<p id="P1">Identification of comparable biomarkers in humans and validated animal
models will facilitate pre-clinical to clinical therapeutic pipelines to treat
neurodevelopmental disorders. Fragile X Syndrome (FXS) is a leading known
genetic cause of intellectual disability with symptoms that include increased
anxiety, social and sensory processing deficits. Recent EEG studies in humans
with FXS have identified neural oscillation deficits that include enhanced
resting state gamma power and reduced inter-trial coherence of sound evoked
gamma oscillations. To determine if analogous phenotypes are present in an
animal model of FXS, we recorded EEGs in awake, freely moving
<italic>Fmr1</italic> knock out (KO) mice using similar stimuli as in the
human studies. We report remarkably similar neural oscillation phenotypes in the
<italic>Fmr1</italic> KO mouse including enhanced resting state gamma power
and reduced evoked gamma synchronization. The gamma band inter-trial coherence
of neural response was reduced in both auditory and frontal cortex of
<italic>Fmr1</italic> KO mice stimulated with a sound whose envelope was
modulated from 1–100 Hz, similar to that seen in humans with FXS. These
deficits suggest a form of enhanced ‘resting state noise’ that
interferes with the ability of the circuit to mount a synchronized response to
sensory input, predicting specific sensory and cognitive deficits in FXS. The
abnormal gamma oscillations are consistent with parvalbumin neuron and
perineuronal net deficits seen in the <italic>Fmr1</italic> KO mouse auditory
cortex indicating that the EEG biomarkers are not only clinically relevant, but
could also be used to probe cellular and circuit mechanisms of sensory
hypersensitivity in FXS.</p>
</abstract>
<kwd-group>
<kwd>Fragile X Syndrome</kwd>
<kwd>autism</kwd>
<kwd>auditory cortex</kwd>
<kwd>sensory hypersensitivity</kwd>
<kwd>frontal cortex</kwd>
<kwd>EEG</kwd>
<kwd>neural oscillations</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>